{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:37:00Z","timestamp":1791239820535,"version":"4.1.0"},"reference-count":157,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.addr.2007.08.017","type":"journal-article","created":{"date-parts":[[2007,8,20]],"date-time":"2007-08-20T12:45:21Z","timestamp":1187613921000},"page":"1482-1503","source":"Crossref","is-referenced-by-count":99,"title":["The effects of pharmaceutical excipients on drug disposition"],"prefix":"10.1016","volume":"59","author":[{"given":"Talia R.","family":"Buggins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glyn","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2007.08.017_bib1","first-page":"59","article-title":"Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters","volume":"5","author":"Bittner","year":"2002","journal-title":"Curr. Opin. Drug Discov. Dev."},{"key":"10.1016\/j.addr.2007.08.017_bib2","first-page":"2112","article-title":"Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL","volume":"56","author":"Sparreboom","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2007.08.017_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/sj.bjc.6690696","article-title":"Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patients","volume":"81","author":"van Tellingen","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.addr.2007.08.017_bib4","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1126\/science.158.3807.1479","article-title":"Pemoline levels in brain: enhancement by dimethyl sulfoxide","volume":"158","author":"Brink","year":"1967","journal-title":"Science"},{"key":"10.1016\/j.addr.2007.08.017_bib5","first-page":"3378","article-title":"Nature of N-nitrosodimethylamine demethylase and its inhibitors","volume":"47","author":"Yoo","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2007.08.017_bib6","first-page":"1","article-title":"Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes","volume":"26","author":"Chauret","year":"1998","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2007.08.017_bib7","first-page":"391","article-title":"In vitro enhancement of microsomal cytochrome P450-dependent monooxygenases by organic solvents in rat liver","volume":"31","author":"Lee","year":"1998","journal-title":"J. Biochem. Mol. Biol."},{"key":"10.1016\/j.addr.2007.08.017_bib8","first-page":"380","article-title":"The effect of solvents on drug metabolism in vitro","volume":"8","author":"Kawalec","year":"1980","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2007.08.017_bib9","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1016\/0006-2952(86)90055-9","article-title":"Effects of organic-solvent vehicles on benzo(a)pyrene metabolism in rabbit lung microsomes","volume":"35","author":"Kontir","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.017_bib10","series-title":"Extrahepatic Drug Metabolism and Chemical Carcinogenesis","first-page":"241","article-title":"Dimethylsulfoxide induced activation of renal microsomal ethoxycoumarin O-deethylation","author":"Zitting","year":"1983"},{"key":"10.1016\/j.addr.2007.08.017_bib11","first-page":"85","article-title":"In vitro reduction of sulindac by rat hepatic cytosolic enzymes","volume":"9","author":"Ratnayake","year":"1981","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2007.08.017_bib12","first-page":"499","article-title":"Effect of dimethylsulfoxide on sulindac disposition in rats","volume":"9","author":"Swanson","year":"1981","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2007.08.017_bib13","first-page":"95","article-title":"Dimethylsulfoxide inhibits bioactivation of sulindac","volume":"102","author":"Swanson","year":"1983","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.addr.2007.08.017_bib14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/15287398309530420","article-title":"Inhibition of sulindac metabolism by dimethylsulfoxide in the rat","volume":"12","author":"Swanson","year":"1983","journal-title":"J. Toxicol. Environ. Health"},{"key":"10.1016\/j.addr.2007.08.017_bib15","first-page":"S104","article-title":"The effects of pharmaceutical excipients on in vivo drug metabolism","volume":"57","author":"Buggins","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.017_bib16","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1001\/jama.244.18.2081","article-title":"Effects of dimethyl sulfoxide on renal function in man","volume":"244","author":"Muther","year":"1980","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2007.08.017_bib17","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/jnnp.49.8.961","article-title":"High plasma osmolality following intravenous dimethylsulfoxide in the treatment of postoperative hemiplegia","volume":"49","author":"Gunn","year":"1986","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.addr.2007.08.017_bib18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1191\/096032701678766859","article-title":"Effect of dimethyl sulfoxide on gentamicin-induced nephrotoxicity in rats","volume":"20","author":"Ali","year":"2001","journal-title":"Human Exp. Toxicol."},{"key":"10.1016\/j.addr.2007.08.017_bib19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.vascn.2006.02.006","article-title":"Effect of commonly used vehicles on gastrointestinal, renal, and liver function in rats","volume":"54","author":"Pestel","year":"2006","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.addr.2007.08.017_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1749-6632.1975.tb25371.x","article-title":"Orally administered dimethyl sulfoxide and its effects on blood concentrations of salicylic acid, sulfanilamide and warfarin","volume":"243","author":"Passananti","year":"1975","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.addr.2007.08.017_bib21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/nt.2620010609","article-title":"Alteration in the tissue retention of [14C]-caffeine in pregnant mice by dimethylsulfoxide","volume":"1","author":"Gross","year":"1993","journal-title":"Nat. Toxins"},{"key":"10.1016\/j.addr.2007.08.017_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1227\/00006123-198301000-00005","article-title":"Effect of dimethyl sulfoxide on the cerebral and systemic circulations of the dog","volume":"12","author":"Kassell","year":"1983","journal-title":"Neurosurgery"},{"key":"10.1016\/j.addr.2007.08.017_bib23","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1128\/AAC.30.4.617","article-title":"Enhancement of ketoconazole penetration across the blood-brain barrier of mice by dimethyl sulfoxide","volume":"30","author":"Iwen","year":"1986","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2007.08.017_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF02003993","article-title":"The effect of dimethyl sulfoxide on tissue distribution of gentamicin","volume":"36","author":"Rubinstein","year":"1980","journal-title":"Experientia"},{"key":"10.1016\/j.addr.2007.08.017_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.toxlet.2003.11.011","article-title":"Acute-phase protein expression in DMSO-intoxicated rats","volume":"147","author":"Ivanovic Matic","year":"2004","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.addr.2007.08.017_bib26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1600-0773.1996.tb00253.x","article-title":"Ethanol interference with morphine metabolism in isolated guinea pig hepatocytes","volume":"79","author":"Aasmundstad","year":"1996","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.addr.2007.08.017_bib27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/03602539709037591","article-title":"Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors","volume":"29","author":"Rendic","year":"1997","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.addr.2007.08.017_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/taap.1996.8025","article-title":"Dose-and route-dependent alterations in metabolism and toxicity of chemical compounds in ethanol-treated rats: difference between highly (Chloroform) and poorly (Carbon tetrachloride) metabolized hepatotoxic compounds","volume":"142","author":"Wang","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.017_bib29","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/carcin\/3.12.1457","article-title":"The induction and competitive inhibition of a high affinity microsomal nitrosodimethylamine demethylase by ethanol","volume":"3","author":"Peng","year":"1982","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.addr.2007.08.017_bib30","first-page":"246","article-title":"Effect of ethanol on oral cocaine pharmacokinetics","volume":"22","author":"Parker","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.addr.2007.08.017_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0376-8716(94)90003-5","article-title":"Alcohol pretreatment alters the metabolic pattern and accelerates cocaine metabolism in pigs","volume":"36","author":"Kambam","year":"1994","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.addr.2007.08.017_bib32","first-page":"7","article-title":"Acute effect of ethanol on hepatic first-pass elimination of propoxyphene in rats","volume":"219","author":"Oguma","year":"1981","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2007.08.017_bib33","first-page":"21","article-title":"The effect of ethanol intake on propoxyphene absorption and biotransformation in dogs","volume":"53","author":"Olsen","year":"1983","journal-title":"Acta Pharmacol. Toxicol."},{"key":"10.1016\/j.addr.2007.08.017_bib34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0741-8329(85)90062-X","article-title":"Ethanol does not increase lethality due to propoxyphene in rats","volume":"2","author":"Bodd","year":"1985","journal-title":"Alcohol"},{"key":"10.1016\/j.addr.2007.08.017_bib35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0378-4274(87)90220-7","article-title":"Comparison of the effects of ethanol and 4-methylpyrazole on the pharmacokinetics and toxicity of ethylene glycol in the dog","volume":"35","author":"Grauer","year":"1987","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.addr.2007.08.017_bib36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1600-0773.1983.tb01125.x","article-title":"Effect of ethanol on the pharmacokinetics of penicillin in the rat","volume":"53","author":"Kourtopoulos","year":"1983","journal-title":"Acta Pharmacol. Toxicol."},{"key":"10.1016\/j.addr.2007.08.017_bib37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0041-008X(86)90368-6","article-title":"Effect of ethanol on organic ion transport in rabbit kidney","volume":"86","author":"Kim","year":"1986","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.017_bib38","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1530-0277.1999.tb04192.x","article-title":"Ethanol feeding does not affect the efficacy or pharmacokinetics of azithromycin, trovafloxacin, or ceftriaxone in a rat model of pneumococcal pneumonia","volume":"23","author":"Preheim","year":"1999","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.addr.2007.08.017_bib39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/phrs.1996.0041","article-title":"Alcohol pretreatment does not affect bupivacaine pharmacokinetics in the pig","volume":"33","author":"Mets","year":"1996","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.addr.2007.08.017_bib40","first-page":"591","article-title":"The effects of acute ethanol intake on isoniazid pharmacokinetics","volume":"47","author":"Dattani","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.017_bib41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0024-3205(95)00291-D","article-title":"Pharmacodynamic interaction between midazolam and a low dose of ethanol in vivo","volume":"57","author":"Hoyo-Vadillo","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2007.08.017_bib42","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jps.2600800309","article-title":"Effects of chronic ethanol ingestion on pharmacokinetics of procainamide in rats","volume":"80","author":"Gole","year":"1991","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2007.08.017_bib43","first-page":"147","article-title":"Ethyl lactate\u2013ethanol\u2013water cosolvent for intravenous theophylline","volume":"50","author":"Christensen","year":"1985","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.017_bib44","first-page":"305","article-title":"Effect of propylene glycol on the disposition of dramamine in the rabbit","volume":"21","author":"Walters","year":"1993","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.addr.2007.08.017_bib45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0041-008X(74)90129-X","article-title":"Propylene glycol as a drug solvent in the study of hepatic microsomal enzyme metabolism in the rat","volume":"28","author":"Dean","year":"1974","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.017_bib46","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0024-3205(93)90138-S","article-title":"The effect of propylene glycol on the P450-dependent metabolism of acetaminophen and other chemicals in subcellular fractions of mouse liver","volume":"52","author":"Snawder","year":"1993","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2007.08.017_bib47","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0306-3623(90)90608-O","article-title":"Propylene glycol enhances anti-inflammatory effects of phenylbutazone","volume":"21","author":"Oshiro","year":"1990","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.017_bib48","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1592\/phco.23.10.1190.32753","article-title":"Acute tubular necrosis associated with propylene glycol from concomitant administration of intravenous lorazepam and trimethoprim-sulfamethoxazole","volume":"23","author":"Hayman","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.addr.2007.08.017_bib49","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1592\/phco.23.10.1094.32762","article-title":"Propylene glycol-associated renal toxicity from lorazepam infusion","volume":"23","author":"Yaucher","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.addr.2007.08.017_bib50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0885-4505(91)90017-F","article-title":"The effect of propane-diols on the intestinal uptake of nutrients and brush-border membrane enzymes in the rat","volume":"45","author":"Morshed","year":"1991","journal-title":"Biochem. Med. Metabol. B"},{"key":"10.1016\/j.addr.2007.08.017_bib51","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2004.03.001","article-title":"Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo","volume":"278","author":"Cornaire","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2007.08.017_bib52","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijpharm.2005.05.004","article-title":"Excipient effects on gastrointestinal transit and drug absorption in beagle dogs","volume":"300","author":"Schulze","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2007.08.017_bib53","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1208\/ps040440","article-title":"An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-a-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine","volume":"4","author":"Johnson","year":"2002","journal-title":"AAPS PharmSci"},{"key":"10.1016\/j.addr.2007.08.017_bib54","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/jps.10176","article-title":"A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro","volume":"91","author":"Hugger","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2007.08.017_bib55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0928-0987(03)00066-6","article-title":"Pharmacokinetics, in-situ absorption and protein binding studies of a new neuroleptic agent centbutindole in rats","volume":"19","author":"Issar","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2007.08.017_bib56","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1023\/A:1020315228237","article-title":"Influence of polyethylene glycol 400 on the gastrointestinal absorption of ranitidine","volume":"19","author":"Basit","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2007.08.017_bib57","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1023\/B:PHAM.0000008046.64409.bd","article-title":"Concentration-dependent effects of polyethylene glycol 400 on gastrointestinal transit and drug absorption","volume":"20","author":"Schulze","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2007.08.017_bib58","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1177\/106002809502901107","article-title":"Polyethylene glycol nephrotoxicity secondary to prolonged high-dose intravenous lorazepam","volume":"29","author":"Laine","year":"1995","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.addr.2007.08.017_bib59","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0006-2952(94)90049-3","article-title":"Microsomal metabolism of N,N-diethylacetamide and N,N-dimethylacetamide and their effects on drug-metabolizing enzymes of rat liver","volume":"48","author":"Menicagli","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.017_bib60","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0378-4274(01)00384-8","article-title":"Inactivation of rat liver cytochrome P450 by N,N-dimethylformamide and N,N-dimethylacetamide","volume":"124","author":"Tolando","year":"2001","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.addr.2007.08.017_bib61","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1528-1157.1995.tb00993.x","article-title":"New injectable aqueous carbamazepine solution through complexing with 2-hydroxypropyl-beta-cyclodextrin \u2014 tolerability and pharmacolkinetics after intravenous injection in comparison to a glycofurol-based formulation","volume":"36","author":"Loscher","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.addr.2007.08.017_bib62","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1016\/0006-2952(78)90200-9","article-title":"Mechanisms in potentiation and inhibition of pharmacological actions of hexobarbital and zoxazolamine by glycofurol","volume":"27","author":"Yasaka","year":"1978","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.017_bib63","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1023\/A:1012136608249","article-title":"Cyclodextrins: their future in drug formulation and delivery","volume":"14","author":"Stella","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2007.08.017_bib64","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1023\/A:1015857902238","article-title":"The effects of cyclodextrins on the disposition of intravenously injected drugs in the rat","volume":"8","author":"Frijlink","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2007.08.017_bib65","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0969-8051(02)00315-3","article-title":"Effect of vehicle on brain uptake of [11C]toluene","volume":"29","author":"Gerasimov","year":"2002","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.addr.2007.08.017_bib66","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1271\/bbb.69.246","article-title":"Interaction of modified cyclodextrins with cytochrome P-450","volume":"69","author":"Ishikawa","year":"2005","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.addr.2007.08.017_bib67","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0378-5173(99)00008-3","article-title":"Methyl-beta-cyclodextrin and doxorubicin pharmacokinetics and tissue concentrations following bolus injection of these drugs alone or together in the rabbit","volume":"180","author":"Grosse","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2007.08.017_bib68","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1248\/bpb1978.10.390","article-title":"Effects of beta-and gamma-cyclodextrins on the pharmacokinetic behavior of prednisolone after intravenous and intramuscular administrations to rabbits","volume":"10","author":"Arimori","year":"1987","journal-title":"J. Pharmacobio-dyn."},{"key":"10.1016\/j.addr.2007.08.017_bib69","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0378-5173(98)00403-7","article-title":"Comparison of the IV pharmacokinetics in sheep of miconazole-cyclodextrin solutions and a micellar solution","volume":"180","author":"Piel","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2007.08.017_bib70","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1213\/01.ANE.0000066019.42467.7A","article-title":"The pharmacokinetics and pharmacodynamics of propofol in a modified cyclodextrin formulation (Captisol) versus propofol in a lipid formulation (Diprivan): an electroencephalographic and hemodynamic study in a porcine model","volume":"97","author":"Egan","year":"2003","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.addr.2007.08.017_bib71","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1213\/00000539-199411000-00020","article-title":"A comparison of two formulations for etomidate, 2-hydroxypropyl-beta-cyclodextrin (HPCD) and propylene glycol","volume":"79","author":"Doenicke","year":"1994","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.addr.2007.08.017_bib72","first-page":"93","article-title":"Influence of dosing vehicles on the preclinical pharmacokinetics of phenolic antioxidants","volume":"104","author":"Vora","year":"1999","journal-title":"Res. Commun. Mol. Pathol."},{"key":"10.1016\/j.addr.2007.08.017_bib73","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpharm.2006.01.011","article-title":"Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin","volume":"312","author":"Liu","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2007.08.017_bib74","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0378-5173(94)00404-S","article-title":"The effect of SBE4-\u03b2-CD on i.v. methylprednisolone pharmacokinetics in rats: comparison to a co-solvent solution and two water-soluble prodrugs","volume":"120","author":"Stella","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2007.08.017_bib75","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0378-5173(94)00405-T","article-title":"The effect of SBE4-\u03b2-CD on i.m. prednisolone pharmacokinetics and tissue damage in rabbits: comparison to a co-solvent solution and a water-soluble prodrug","volume":"120","author":"Stella","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2007.08.017_bib76","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/jps.2600800620","article-title":"Effect of hydrotropic substances on the complexation of sparingly soluble drugs with cyclodextrin derivatives and the influence of cyclodextrin complexation on the pharmacokinetics of the drugs","volume":"80","author":"Muller","year":"1991","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2007.08.017_bib77","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/jps.2600830615","article-title":"Parenteral hydroxypropyl cyclodextrins: intravenous and intracerebral administration of lipophiles","volume":"83","author":"Pitha","year":"1994","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2007.08.017_bib78","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0378-5173(02)00559-8","article-title":"Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole","volume":"250","author":"Garc\u00eda","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2007.08.017_bib79","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejps.2006.01.011","article-title":"Pharmacokinetic study of a new synthetic MMP inhibitor (Ro 28-2653) after IV and oral administration of cyclodextrin solutions","volume":"28","author":"Piette","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2007.08.017_bib80","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijpharm.2006.02.035","article-title":"Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin","volume":"316","author":"Lee","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2007.08.017_bib81","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/jps.20198","article-title":"Beta-cyclodextrin reduces bioavailability of orally administered [3H]benzo[a]pyrene in the rat","volume":"94","author":"Westerberg","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2007.08.017_bib82","first-page":"200","article-title":"Effects of 2-hydroxypropyl-beta-cyclodextrin on pharmacokinetics of digoxin in rabbits and humans","volume":"59","author":"He","year":"2004","journal-title":"Pharmazie"},{"key":"10.1016\/j.addr.2007.08.017_bib83","unstructured":"BASF Aktiengesellschaft, Solubilizers, solvents and co-solvents, [WWW]<http:\/\/www.basf-pharma.com\/solubilizers_solvents_cosolvents.aspx>(2004) [accessed 21 July 2007]."},{"key":"10.1016\/j.addr.2007.08.017_bib84","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2165\/00003088-200342070-00005","article-title":"Pharmacological effects of formulation vehicles \u2014 implications for cancer chemotherapy","volume":"42","author":"ten Tije","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.addr.2007.08.017_bib85","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","article-title":"Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation","volume":"37","author":"Gelderblom","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.addr.2007.08.017_bib86","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1208\/ps050432","article-title":"Pharmacokinetics of paclitaxel-containing liposomes in rats","volume":"5","author":"Fetterly","year":"2003","journal-title":"AAPS PharmSci"},{"key":"10.1016\/j.addr.2007.08.017_bib87","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0168-3659(01)00275-9","article-title":"In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy","volume":"72","author":"Kim","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2007.08.017_bib88","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/bjc.1996.90","article-title":"Effect of the paclitaxel vehicle, Cremophor EL, on the pharmacokinetics of doxorubicin and doxorubicinol in mice","volume":"73","author":"Webster","year":"1996","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.addr.2007.08.017_bib89","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1751-1097.1995.tb02409.x","article-title":"Photodynamic activities and skin photosensitivity of the bis(dimethylthexylsiloxy)silicon 2,3-naphthalocyanine in mice","volume":"62","author":"Brasseur","year":"1995","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.addr.2007.08.017_bib90","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1211\/0022357023303","article-title":"Disposition kinetics of taxanes after intraperitoneal administration in rats and influence of surfactant vehicles","volume":"56","author":"Yokogawa","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.017_bib91","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpharm.2004.12.023","article-title":"Cremophor EL releases cyclosporin A adsorbed on blood cells and blood vessels, and increases apparent plasma concentration of cyclosporin A","volume":"293","author":"Jin","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2007.08.017_bib92","first-page":"1454","article-title":"Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications","volume":"59","author":"Sparreboom","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2007.08.017_bib93","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/bjc.1994.317","article-title":"Effects of cremophor EL on distribution of taxol to serum lipoproteins","volume":"70","author":"Sykes","year":"1994","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.addr.2007.08.017_bib94","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1751-1097.1994.tb05083.x","article-title":"Biodistribution and PDT efficacy of a ketochlorin photosensitizer as a function of the delivery vehicle","volume":"60","author":"Woodburn","year":"1994","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.addr.2007.08.017_bib95","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/1357-2725(95)00030-S","article-title":"Interactions of Solutol HS 15 and Cremophor EL with plasma lipoproteins","volume":"27","author":"Woodburn","year":"1995","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.addr.2007.08.017_bib96","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/bdd.383","article-title":"In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam","volume":"25","author":"Bravo Gonzalez","year":"2004","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.addr.2007.08.017_bib97","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0009-9236(03)00010-9","article-title":"\u201cInactive\u201d excipients such as Cremophor can affect in vivo drug disposition","volume":"73","author":"Wandel","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2007.08.017_bib98","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s002800050451","article-title":"Inhibition of etoposide elimination in the isolated perfused rat liver by Cremophor EL and Tween 80","volume":"38","author":"Ellis","year":"1996","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.017_bib99","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s002800050857","article-title":"Inhibition of paclitaxel elimination in the isolated perfused rat liver by Cremophor EL","volume":"43","author":"Ellis","year":"1999","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.017_bib100","first-page":"50","article-title":"Effect of cyclosporine on colchicine secretion by the kidney multidrug transporter studied in vivo","volume":"261","author":"Speeg","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.addr.2007.08.017_bib101","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1432-2277.1993.tb00753.x","article-title":"Dissolving intravenous cyclosporin A in a fat emulsion carrier prevents acute renal side effects in the rat","volume":"6","author":"Tibell","year":"1993","journal-title":"Transpl. Int."},{"key":"10.1016\/j.addr.2007.08.017_bib102","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00007890-198708000-00005","article-title":"Use of the isolated perfused kidney model to assess the acute pharmacologic effects of cyclosporine and its vehicle, cremophor EL","volume":"44","author":"Besarab","year":"1987","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2007.08.017_bib103","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/jps.10395","article-title":"The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins","volume":"92","author":"Bogman","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2007.08.017_bib104","first-page":"1937","article-title":"Disposition of Cremophor EL in humans limits the potential for modulation of the multidrug resistance phenotype in vivo","volume":"4","author":"Sparreboom","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2007.08.017_bib105","first-page":"576","article-title":"Effect of polyoxyl 35 castor oil and Polysorbate 80 on the intestinal absorption of digoxin in vitro","volume":"50","author":"Cornaire","year":"2000","journal-title":"Arzneim.-Forsch."},{"key":"10.1016\/j.addr.2007.08.017_bib106","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0009-9236(03)00059-6","article-title":"Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40","volume":"73","author":"Tayrouz","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2007.08.017_bib107","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1046\/j.1365-2125.2002.01595.x","article-title":"Dose-dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor EL","volume":"53","author":"Martin-Facklam","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.017_bib108","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00280-001-0394-2","article-title":"Entrapment by Cremophor EL decreases the absorption of paclitaxel from the gut","volume":"49","author":"Bardelmeijer","year":"2002","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.017_bib109","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1054\/bjoc.2001.2118","article-title":"The co-solvent Cremophor EL limits absorption of orally administered paclitaxel in cancer patients","volume":"85","author":"Malingre","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.addr.2007.08.017_bib110","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/jps.20017","article-title":"Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes","volume":"93","author":"Shono","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2007.08.017_bib111","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00280-004-0928-5","article-title":"Preclinical pharmacokinetics and oral bioavailability of BMS-310705, a novel epothilone B analog","volume":"56","author":"Kamath","year":"2005","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"Suppl 2","key":"10.1016\/j.addr.2007.08.017_bib112","first-page":"499","article-title":"Randomised, cross-over trial to determine the effect of Cremophor on the pharmacokinetics and pharmacodynamics of carboplatin-based therapy","volume":"9","author":"Millward","year":"1998","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.addr.2007.08.017_bib113","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-0773.1995.tb00115.x","article-title":"Cyclosporin A in fat emulsion carriers: experimental studies on pharmacokinetics and tissue distribution","volume":"76","author":"Tibell","year":"1995","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.addr.2007.08.017_bib114","first-page":"312","article-title":"Role of the carrier solution in cyclosporine pharmacokinetics in the baboon","volume":"5","author":"Kurlansky","year":"1986","journal-title":"J. Heart Transplant."},{"key":"10.1016\/j.addr.2007.08.017_bib115","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/00001813-199810000-00011","article-title":"Effect of Cremophor EL on the pharmacokinetics, antitumor activity and toxicity of doxorubicin in mice","volume":"9","author":"Badary","year":"1998","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.addr.2007.08.017_bib116","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1023\/A:1008309916974","article-title":"Pharmacokinetic interactions of paclitaxel, docetaxel and their vehicles with doxorubicin","volume":"10","author":"Colombo","year":"1999","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.addr.2007.08.017_bib117","first-page":"2849","article-title":"Increased penetration of paclitaxel into the brain by inhibition of P-glycoprotein","volume":"9","author":"Kemper","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2007.08.017_bib118","first-page":"1237","article-title":"Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel","volume":"8","author":"Gelderblom","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2007.08.017_bib119","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1021\/js970118m","article-title":"Propofol pharmacokinetics and pharmacodynamics assessed from a Cremophor EL formulation","volume":"86","author":"Dutta","year":"1997","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2007.08.017_bib120","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/BF02976689","article-title":"Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats","volume":"26","author":"Zhang","year":"2003","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.addr.2007.08.017_bib121","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/BF00258124","article-title":"The distribution and elimination of methotrexate in mouse blood and brain after concurrent administration of polysorbate 80","volume":"14","author":"Azmin","year":"1985","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.017_bib122","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0378-5173(00)00586-X","article-title":"Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450","volume":"211","author":"Mountfield","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2007.08.017_bib123","first-page":"2918","article-title":"Rapid esterase-sensitive breakdown of polysorbate 80 and its impact on the plasma pharmacokinetics of docetaxel and metabolites in mice","volume":"5","author":"van Tellingen","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.addr.2007.08.017_bib124","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0009-9236(03)00222-4","article-title":"Clinical pharmacokinetics of unbound docetaxel: role of polysorbate 80 and serum proteins","volume":"74","author":"Loos","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2007.08.017_bib125","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1211\/0022357011775343","article-title":"Increased vigabatrin entry into the brain by polysorbate 80 and sodium caprate","volume":"53","author":"Dimitrijevic","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.017_bib126","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1023\/A:1018983904537","article-title":"Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles","volume":"16","author":"Gulyaev","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2007.08.017_bib127","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1166\/jnn.2003.077","article-title":"Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain","volume":"4","author":"Kreuter","year":"2004","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.addr.2007.08.017_bib128","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0014-2964(81)90246-2","article-title":"Tween 80 increases plasma adriamycin concentrations in mice by a apparent reduction of plasma volume","volume":"17","author":"Harrison","year":"1981","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.addr.2007.08.017_bib129","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF00299871","article-title":"Influence of polysorbate-80 (Tween-80)and etoposide (VP-16-213) on the pharmacokinetics and urinary excretion of adriamycin and its metabolites in cancer patients","volume":"17","author":"Cummings","year":"1986","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.017_bib130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijpharm.2004.04.010","article-title":"In vitro investigation on the impact of Solutol HS 15 on the uptake of colchicine into rat hepatocytes","volume":"279","author":"Bravo Gonzalez","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2007.08.017_bib131","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/02652049809006836","article-title":"Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study","volume":"15","author":"Alyautdin","year":"1998","journal-title":"J. Microencapsul."},{"issue":"S1","key":"10.1016\/j.addr.2007.08.017_bib132","first-page":"364","article-title":"Impact of Solutol HS 15 on the clearance of midazolam in rat hepatocytes","volume":"33","author":"Bravo Gonzalez","year":"2001","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.addr.2007.08.017_bib133","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0939-6411(03)00041-9","article-title":"Impact of Solutol HS 15 on the pharmacokinetic behaviour of midazolam upon intravenous administration to male Wistar rats. Eur","volume":"56","author":"Bittner","year":"2003","journal-title":"J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2007.08.017_bib134","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/bdd.353","article-title":"Impact of Solutol HS 15 on the pharmacokinetic behaviour of colchicine upon intravenous administration to male Wistar rats","volume":"24","author":"Bittner","year":"2003","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.addr.2007.08.017_bib135","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0024-3205(97)00370-6","article-title":"Effect of the P-glycoprotein inhibitor, SDZ PSC 833, on the blood and brain pharmacokinetics of colchicine","volume":"61","author":"Desrayaud","year":"1997","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2007.08.017_bib136","first-page":"897","article-title":"Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance","volume":"51","author":"Coon","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2007.08.017_bib137","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/bjc.1992.217","article-title":"Reversal of multidrug resistance by surfactants","volume":"66","author":"Woodcock","year":"1992","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.addr.2007.08.017_bib138","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2174\/1570180053765165","article-title":"Impact of oral administration of the surface-active excipient Solutol HS 15 on the pharmacokinetics of intravenously administered colchicine","volume":"2","author":"Bittner","year":"2005","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.addr.2007.08.017_bib139","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0378-5173(02)00339-3","article-title":"Improved oral bioavailability of cyclosporin A in male Wistar rats. Comparison of a Solutol HS15 containing self-dispersing formulation and a microsuspension","volume":"245","author":"Bravo Gonzalez","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2007.08.017_bib140","first-page":"684","article-title":"Improvement of the bioavailability of colchicine in rats by co-administration of d-alpha-tocopherol polyethylene glycol 1000 succinate and a polyethoxylated derivative of 12-hydroxy-stearic acid","volume":"52","author":"Bittner","year":"2002","journal-title":"Arzneim-Forsch."},{"key":"10.1016\/j.addr.2007.08.017_bib141","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.2042-7158.1998.tb03302.x","article-title":"Formulation-dependent pharmacokinetics and pharmacodynamics of propofol in rats","volume":"50","author":"Dutta","year":"1998","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.017_bib142","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/00000542-199809000-00018","article-title":"Formulation-dependent brain and lung distribution kinetics of propofol in rats","volume":"89","author":"Dutta","year":"1998","journal-title":"Anesthesiology"},{"key":"10.1016\/j.addr.2007.08.017_bib143","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1439-0442.2000.00289.x","article-title":"Cardiopulmonary side-effects and pharmacokinetics of an emulsion of propofol (Disoprivan (R)) in comparison to propofol solved in polysorbate 80 in goats","volume":"47","author":"Bettschart-Wolfensberger","year":"2000","journal-title":"J. Vet. Med., Ser. A"},{"key":"10.1016\/j.addr.2007.08.017_bib144","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0378-5173(02)00490-8","article-title":"Pharmacokinetic and pharmacodynamic evaluation of cyclosporin A O\/W-emulsion in rats","volume":"249","author":"Kim","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2007.08.017_bib145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0378-5173(99)00080-0","article-title":"Phospholipid-based microemulsions of flurbiprofen by the spontaneous emulsification process","volume":"183","author":"Park","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2007.08.017_bib146","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1248\/bpb.19.252","article-title":"Pharmacokinetics of highly lipophilic antitumor agent palmitoyl rhizoxin incorporated in lipid emulsions in rats","volume":"19","author":"Kurihara","year":"1996","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.addr.2007.08.017_bib147","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/10611869509015949","article-title":"O\/W lipid emulsions for parenteral drug delivery. II. Effect of composition on pharmacokinetics of incorporated drug","volume":"3","author":"Sakaeda","year":"1995","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2007.08.017_bib148","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.2042-7158.1989.tb06534.x","article-title":"The effect of Miglycol 812 oil on the oral absorption of propranolol in the rat","volume":"41","author":"Woolfrey","year":"1989","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.addr.2007.08.017_bib149","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jac\/dkg266","article-title":"Comparative pharmacokinetics and safety of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and amphotericin B deoxycholate in animal models","volume":"52","author":"Brime","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.addr.2007.08.017_bib150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0378-5173(00)00680-3","article-title":"Pharmacokinetic behavior of cyclosporin A in rabbits by oral administration of lecithin vesicle and sandimmun neoral","volume":"216","author":"Guo","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2007.08.017_bib151","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0378-5173(99)00029-0","article-title":"Preparation and evaluation of flurbiprofen-loaded microemulsion for parenteral delivery","volume":"181","author":"Park","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2007.08.017_bib152","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1248\/bpb.25.492","article-title":"Role of the lipid emulsion on an injectable formulation of lipophilic KW-3902, a newly synthesized adenosine A1-receptor antagonist","volume":"25","author":"Hosokawa","year":"2002","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.addr.2007.08.017_bib153","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1023\/A:1011980432646","article-title":"Influence of different fat emulsion-based intravenous formulations on the pharmacokinetics and pharmacodynamics of propofol","volume":"15","author":"Cox","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2007.08.017_bib154","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/00000539-199712000-00040","article-title":"Pharmacokinetics and pharmacodynamics of propofol in a new solvent","volume":"85","author":"Doenicke","year":"1997","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.addr.2007.08.017_bib155","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1046\/j.1365-2044.2003.03345.x","article-title":"Pharmacological characteristics and side effects of a new galenic formulation of propofol without soyabean oil","volume":"58","author":"Paul","year":"2003","journal-title":"Anaesthesia"},{"key":"10.1016\/j.addr.2007.08.017_bib156","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/00000542-200212000-00011","article-title":"Pharmacodynamics and pharmacokinetics of propofol in a medium-chain triglyceride emulsion","volume":"97","author":"Ward","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.addr.2007.08.017_bib157","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s002280050726","article-title":"Pharmacokinetics and pharmacodynamics of propofol 6% SAZN versus propofol 1% SAZN and Diprivan-10 for short-term sedation following coronary artery bypass surgery","volume":"56","author":"Knibbe","year":"2000","journal-title":"Eur. J. Clin. Pharmacol."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X07001810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X07001810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T08:54:38Z","timestamp":1556787278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X07001810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":157,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0169409X07001810"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2007.08.017","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}